CheckMyRecalls

Amerisource Health Services LLC recalls glipiZIDE

Published
22 Jan 2025
Units affected
2,028 units (cartons of 30 individual unit doses)
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications:

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Brand / company
Amerisource Health Services LLC
Codes / lots
Lot # 1012910, Exp Date: 04/30/2025
Distribution
Nationwide in the USA
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 22 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.